Literature DB >> 28215280

Molecular Mechanisms of Somatic Hypermutation and Class Switch Recombination.

S P Methot1, J M Di Noia2.   

Abstract

In order to promote an efficient humoral immune response, germinal center B cells modify both the antigen recognition and effector domains by programmed genetic alterations of their antibody genes. To do so, B cells use the enzyme activation-induced deaminase (AID), which transforms deoxycytidine into deoxyuridine at the immunoglobulin genes, triggering mutagenic DNA repair. Data accumulated during the past decade have significantly advanced our understanding of how AID activity is regulated and preferentially targeted to the immunoglobulin genes. There is also a better understanding of the ways by which AID-catalyzed uracil is recognized and the ensuing downstream processing underpinning the mechanisms of somatic hypermutation and class switch recombination. Here, we critically review these advances in the context of their relevance for the humoral immune response. A detailed understanding of these molecular mechanisms is paramount to uncover the basis of B cell intrinsic immunodeficiency, as well as to suggest tools and strategies that might allow boosting antibody gene diversification in the context of immunizations or infections that require the elicitation of rare or highly mutated antibody variants.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activation-induced deaminase; Antibody response; B-lymphocytes; Class switch recombination; DNA double strand break repair; Germinal center; Immunoglobulin gene conversion; Mismatch DNA repair; Somatic hypermutation; Uracil-DNA glycosylase

Mesh:

Substances:

Year:  2016        PMID: 28215280     DOI: 10.1016/bs.ai.2016.11.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  90 in total

1.  DNA double-strand break response factors influence end-joining features of IgH class switch and general translocation junctions.

Authors:  Rohit A Panchakshari; Xuefei Zhang; Vipul Kumar; Zhou Du; Pei-Chi Wei; Jennifer Kao; Junchao Dong; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).

Authors:  Kathryn E Stephenson; Frank Wegmann; Frank Tomaka; Stephen R Walsh; C Sabrina Tan; Ludo Lavreys; Jessica L Ansel; Diane G Kanjilal; Kate Jaegle; Joseph P Nkolola; Lauren Peter; Rachel Fogel; Connor Bradshaw; Anna Tyler; Tatenda Makoni; Lisa Howe; Darla Quijada; Abishek Chandrashekar; Esther A Bondzie; Erica N Borducchi; Katherine E Yanosick; Jenny Hendriks; Steven Nijs; Carla Truyers; Jeroen Tolboom; Roland C Zahn; Michael S Seaman; Galit Alter; Daniel J Stieh; Maria Grazia Pau; Hanneke Schuitemaker; Dan H Barouch
Journal:  Lancet HIV       Date:  2020-02-17       Impact factor: 12.767

Review 3.  Shieldin - the protector of DNA ends.

Authors:  Dheva Setiaputra; Daniel Durocher
Journal:  EMBO Rep       Date:  2019-04-04       Impact factor: 8.807

4.  Guiding a mutator in antibody diversification.

Authors:  Ming Tian; Frederick W Alt
Journal:  Cell Res       Date:  2018-10       Impact factor: 25.617

5.  Lack of Evidence for a Substantial Rate of Templated Mutagenesis in B Cell Diversification.

Authors:  Julia Fukuyama; Branden J Olson; Frederick A Matsen
Journal:  J Immunol       Date:  2020-07-15       Impact factor: 5.422

6.  A Genetic Map of the Response to DNA Damage in Human Cells.

Authors:  Michele Olivieri; Tiffany Cho; Alejandro Álvarez-Quilón; Kejiao Li; Matthew J Schellenberg; Michal Zimmermann; Nicole Hustedt; Silvia Emma Rossi; Salomé Adam; Henrique Melo; Anne Margriet Heijink; Guillermo Sastre-Moreno; Nathalie Moatti; Rachel K Szilard; Andrea McEwan; Alexanda K Ling; Almudena Serrano-Benitez; Tajinder Ubhi; Sumin Feng; Judy Pawling; Irene Delgado-Sainz; Michael W Ferguson; James W Dennis; Grant W Brown; Felipe Cortés-Ledesma; R Scott Williams; Alberto Martin; Dongyi Xu; Daniel Durocher
Journal:  Cell       Date:  2020-07-09       Impact factor: 41.582

Review 7.  Brain cell somatic gene recombination and its phylogenetic foundations.

Authors:  Gwendolyn Kaeser; Jerold Chun
Journal:  J Biol Chem       Date:  2020-07-22       Impact factor: 5.157

8.  Cutting Edge: ATM Influences Germinal Center Integrity.

Authors:  Laura Nicolas; Montserrat Cols; Ryan Smolkin; Keith C Fernandez; William T Yewdell; Wei-Feng Yen; Shan Zha; Bao Q Vuong; Jayanta Chaudhuri
Journal:  J Immunol       Date:  2019-04-26       Impact factor: 5.422

9.  TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the Aicda superenhancer.

Authors:  Chan-Wang J Lio; Vipul Shukla; Daniela Samaniego-Castruita; Edahi González-Avalos; Abhijit Chakraborty; Xiaojing Yue; David G Schatz; Ferhat Ay; Anjana Rao
Journal:  Sci Immunol       Date:  2019-04-26

10.  AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.

Authors:  J Jiao; Y Jin; M Zheng; H Zhang; M Yuan; Z Lv; W Odhiambo; X Yu; P Zhang; C Li; Y Ma; Y Ji
Journal:  Clin Exp Immunol       Date:  2018-11-13       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.